Skip to main content
Scott E.
Lindner
Associate Professor of Biochemistry and Molecular Biology
Scott Lindner

About Me

Dr. Scott E. Lindner was born and raised in Chicagoland. He did his undergraduate training at the Florida Institute of Technology (Melbourne, FL), which is far warmer than Chicago in the winter. Dr. Lindner then completed his Ph.D. in Cancer Biology at the McArdle Laboratory for Cancer Research at the University of Wisconsin-Madison, which is slightly colder than Chicago in the winter. Dr. Lindner conducted post-doctoral training in x-ray crystallography (University of Wisconsin-Madison), as well as molecular parasitology at the Seattle Biomedical Research Institute, which is far rainier than Chicago. Since 2013, Dr. Lindner has been a faculty member in the Department of Biochemistry and Molecular Biology at Penn State University in State College, PA, which he finds to be a lovely place to live and work.

 

Department or University Committees

  • Seminars and Distinguished Lectures, Chair Graduate Student Recruitment Safety

 

Program or Department Affiliations

The BMMB Graduate Program Molecular, Cellular, and Integrative Biosciences

Editorial Boards

Associate Editor, Frontiers in Cellular and Infection Microbiology Ad hoc Reviewer, NIAID Eukaryotic Pathogens (PTHE)

Centers

Center for Malaria Research

Center for Infectious Disease Dynamics Center for RNA Molecular Biology

 

Research Summary

Our laboratory couples molecular parasitology and structural biology to study the malaria parasite (Plasmodium spp.). Malaria is still one of the great global health challenges today. Conservative estimates from the World Health Organization indicate that, every year, about 500 million people become infected, and of these people nearly 1 million people will die from their infection. Significant efforts have been made to develop new drugs and vaccines, however, the mounting resistance to these drugs and the limited efficacy of the current generation of vaccines have not allowed for the goals of elimination and eradication of the parasite to be met.

In response to this, our laboratory conducts Discovery Phase research using the mouse-infective malaria parasite Plasmodium yoelii in three key areas that focus upon crucial aspects of the parasite’s growth, development, and transmission.

 

1. Translational Regulation During Parasite Transmission

Our group is building upon our previous work that uncovered the importance of specific protein/RNA complexes for the maintenance of parasite infectivity during transmission from a mosquito to a mammal. This work is supported by a K22 Research Scholar Development Award from the NIAID, and will push the practical and technical boundaries of doing practical biochemistry with the sporozoite stage of the malaria parasite. Through this work, we hope to uncover how the parasite produces and maintains this latent infectious state as it awaits the unpredictable moment of transmission from the mosquito.

Translational Regulation During Parasite Transmission

 

 

Transcriptional Regulation by Specific Transcription Factors

2. Transcriptional Regulation by Specific Transcription Factors

In collaboration with Dr. Manuel Llinás, we have produced the first x-ray crystallographic model of an ApiAP2 specific transcription factor bound to its cognate double-stranded DNA binding site. Additional research has demonstrated that this family of proteins is widely important, as they function to regulate the parasite’s gene expression dynamics both generally and during specific developmental stages. Through this work with Dr. Llinás, we hope to further characterize these key regulatory mechanisms by building upon our atomic-level understanding of the ApiAP2 protein family.

 

 

 

Comprehensive Proteomics

3. Comprehensive Proteomics

In collaboration with Drs. Stefan Kappe, Robert Moritz and Photini Sinnis, our Bill and Melinda Gates Foundation supported work has produced the most comprehensive total proteome of a mosquito stage parasite (salivary gland sporozoite) to date. Additionally, we have adapted labeling techniques to identify novel surface proteins of the salivary gland sporozoite, which may prove to be valid candidates for antibody-based vaccines. Through this collaborative work, we hope to identify the dynamics of protein utilization during infection to exploit these events therapeutically.

 

 

 

Honors or Awards

2019

Keynote Speaker, Future of Malaria Research Symposium

2019

Co-Organizer, Pennsylvania Parasitology Conference (PAraCon 2019)

2018

Co-Organizer, Pennsylvania Parasitology Conference (PAraCon 2018)

2018

BioMalPar; EMBL, Heidelberg, Germany. CRISPR Workshop Co-Chair

2014

ASTMH Pre-Meeting Course, Advances in Proteomics and Metabolomics: Toward Dissecting Host-Pathogen Interactions; Co-Organizer (with Manuel Llinás)

2013 - 2015

NIAID K22 Research Scholar Development Award

2010

U. Washington / Howard Hughes Medical Institute (HHMI) Future Faculty Fellow

2009 - 2011

NIAID F32 Ruth L. Kirschstein NRSA Postdoctoral Fellow

2009

Molecular Parasitology Meeting, Award for Excellent Oral Presentation

2001

Graduated with magna cum laude distinction, Florida Institute of Technology

2001

Frank G. Brooks Award for Excellence in Student Research, Tri-Beta District I

2000 - 2001

Tri-Beta National Biological Honor Society

2000 - 2001

Outstanding Senior in Molecular Biology, Florida Institute of Technology

1997 - 2001

Presidential Scholarship, Florida Institute of Technology

1997 - 2001

Dean’s List, Florida Institute of Technology

 

Selected Publications